Giorgio Pennazza

TL;DR: Application of breath biomarker measurement in a standardised manner will provide comparable results, thereby facilitating the potential use of these biomarkers in clinical practice, and highlighting future research priorities in the field.

TL;DR: In this paper an experiment, performed in the bronchoscopy unit of a large hospital, aimed at discriminating between lung cancer, diverse lung diseases and reference controls is illustrated, showing not only a satisfactory identification rate of lung cancer subjects but also a non-negligible sensitivity to breath modification induced by other affections.

TL;DR: Clustering based on clinicophysiologic parameters yielded 4 stable and reproducible clusters of asthmatic patients that associate with different pathobiological pathways.

TL;DR: The electronic nose has a high diagnostic performance that can be increased when combined with FENO and MS fingerprints of VOCs could discriminate between patients with asthma and healthy subjects.

TL;DR: An overview of the electronic nose (EN) applications in medicine and in particular with recent data related to the following pathologies: lung cancer, schizophrenia, melanoma will be illustrated and commented.